EDITORIAL
Ozone
as a complement therapy in the treatment of COVID-19
Ozonoterapia como terapia
complementar no tratamento da COVID-19
Jorge Bomfim Fróes de Farias1, Antonio
Pedro Fróes de Farias2,3, Anelize Gimenez de Souza4
1Nucleus Reabilitação
Cardíaca, Santo Antônio de Jesus, BA - Brasil
2Faculdade de Ciências e
Empreendedorismo (FACEMP), Santo Antônio de Jesus, BA - Brasil
3Universidade Federal da
Bahia (UFBA), Salvador, BA - Brasil
4Faculdade Nobre (FAN),
Feira de Santana, BA - Brasil
Received
on 2020, April 16; Accepted on: 2020, April 27.
Corresponding author: Jorge Bomfim Fróes de Farias, Av. Barros e Almeida, 114 Centro 44571-013
Santo Antônio de Jesus BA
Jorge Bomfim Fróes de Farias: jbfroes@hotmail.com
Antonio Pedro Fróes de Farias: froes_pedro@hotmail.com
Anelize Gimenez de Souza:
ane_gimenez@hotmail.com
The emergence of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) called “coronavirus 2019” (COVID-19), has become a threat to the
general population and health professionals worldwide [1]. The clinical
features of COVID-19 is like that of other respiratory viruses, with
specifically, fever, generally dry cough, tiredness and, in more severe cases,
dyspnea, pulmonary bleeding, severe lymphopenia and renal failure [2].
For diagnosis, the World Health Organization (WHO) recommends the
collection of samples from the upper or lower respiratory tract. In the
laboratory, the amplification of the genetic material extracted from the saliva
or mucus sample is carried out by means of a reverse transcription followed by
a polymerase chain reaction (RT-PCR), which involves the synthesis of a
double-stranded DNA molecule from of an RNA template, in the search for
conserved parts of the coronavirus genetic code. In patients with a confirmed
diagnosis, the laboratory test should be repeated to assess the release of
viral particles, before leaving the isolation [3].
The clinical manifestation and severity of the disease is directly
related to the health condition of the infected individual. Symptoms are often
mild as in a common cold or flu and it can progress to pneumonia. Ventilatory
support therapy such as oxygen therapy and/or mechanical ventilation is
necessary as an intervention method in the most severe cases of the disease
[4]. Individuals with chronic respiratory diseases and other comorbidities can
present the most severe form of COVID-19 and, for this reason, care with
prevention should be emphasized [5].
Although there is no specific recommended antiviral treatment and no
vaccine available, several therapeutic approaches have been proposed, such as:
lopinavir/ritonavir [6]; chloroquine/hydroxychloroquine [7]; alpha interferon
[8]; and remdesivir, an RNA polymerase inhibitor with
in vitro activity against several RNA viruses, which have been shown to be
effective in preclinical trials in the treatment of coronavirus infections [9].
In this moment of serious global health crisis, we highlight the
possibility of using ozone gas or ozone therapy as an adjuvant in the antiviral
treatment of COVID-19. Ozone gas (O3) is a molecule that consists of
three oxygen atoms in a dynamically unstable structure due to the presence of mesomeric states. The gas is colorless, has a bitter odor
and its basic function is to protect humans from the harmful effects of
ultraviolet radiation. Ozone is a natural compound that is easily generated in
situ from oxygen or air and decomposes into oxygen with a half-life of about 20
minutes [10,11].
Ozone therapy is a technique that uses an oxygen-ozone gas mixture for
medicinal purposes. This technique assumes that O3 dissociates
quickly and releases a reactive form of oxygen that can oxidize cells,
increasing the availability of oxygen and ATP for cellular activity [11]. Ozone
increases the rate of glycolysis of red blood cells, stimulating
2,3-diphosphoglycerate, promoting an increase in the amount of oxygen released
to the tissues. Additionally, it activates the Krebs cycle, improving the
oxidative carboxylation of pyruvate, stimulating the production of ATP. It also
leads to a significant reduction in NADH and helps to oxidize cytochrome C. The
production of prostacyclin, a potent vasodilator, is also induced by O3 [10,12].
Ozone is deemed to be a prodrug, since it
induces the activation of a biochemical cascade with multiple systemic
antioxidant actions (Figure 1) [10,11]. O3 reacts with all
biomolecules in cell membranes, including lipids, proteins, carbohydrates and
DNA [13]. The unsaturated fatty acid, which is found in cell membrane
phospholipids, reacts with O3 to generate hydrogen peroxide (H2O2)
and 4-hydroxinonenal aldehyde (4-HNE). H2O2 promotes the
transcription factor Nrf2 pathway and protein synthesis, which favor cell
survival. Degradation of 4-HNE sends a signal of transient oxidative stress,
activating the synthesis of various substances that respond to cellular
oxidative stress such as: y-glutamyl transpeptidase, heat shock protein 70
(HSP-70), hemoglobin oxygenase-1 (HO-1); in addition to antioxidant enzymes,
such as superoxide dismutase, glutathione peroxidase, catalase and
glucose-6-phosphate dehydrogenase (G6PDH). This process represents the basis of
the paradoxical phenomenon, for which an oxidizing molecule, such as O3,
triggers a potent antioxidant reaction [11-13].
Adapted
from Sciorsci et al. [11]. O3 = Ozone; H2O2 =
hydrogen peroxide; 4-HNE = 4-hydroxynonenal; Nrf2 = erythroid nuclear factor 2
related to factor 2; SOD = superoxide dismutase; GSH-Px = glutathione
peroxidase; G6PDH = glucose-6-phosphate dehydrogenase; HSP-70 = heat shock
protein 70; HO-1 = hemoglobin oxygenase 1.
Figure
1 - The ozone mechanism of action.
The use of ozone has been shown to inactivate different microorganisms,
such as bacteria, fungi and different viral strains, including the coronavirus
[14]. Coronavirus is an enveloped RNA virus where glycoproteins rich in
cysteine present in the viral envelope assist in recognition by host cells [3].
Cysteine contains a reduced thiol or sulfhydryl (-SH) group, essential for
fusion and entry of the virus into the cell. Sulfhydryl groups are vulnerable
to oxidation and, therefore, susceptible to ozone, due to their oxidizing
power. Peroxides created by ozone administration oxidize cysteines and show
antiviral effects that can serve to reduce viral load [15,16].
The immunological action of ozone is fundamentally directed on monocytes
and T lymphocytes, which, once induced, release small amounts of cytokines,
such as: interferon-gamma (IFN-g) tumor necrosis factor (TNF) and
interleukin-2 (IL-2). The modulating activity of inflammation and the
improvement of oxygenation in tissues, in combination with the induction of the
activation of antibodies and cytokines, help to structure the immune response
to fight several viral types [10,16].
Thus, ozone therapy may be potentially useful for SARS-CoV-2 infection
in two therapeutic categories: surface disinfection [14]; or in systemic use as
an additional compound, in order to improve the health status of patients and
reduce viral load [17]. The mechanism of action has already been proven in
other viral infections and involves: 1) induction of adaptation to oxidative
stress, with restoration of the balance of the redox state of the cells; 2)
induction of IFN-g and pro-inflammatory cytokines; 3) increased blood flow and oxygenation
of vital organ tissues; 4) in addition to being able to act as an autovaccine
when administered systemically in the form of autohemotherapy [17].
This is a time of vigilance, common sense and scientific investigation
[2]. Some clinical studies using ozone therapy are being carried out in China
and Italy to determine the effectiveness of this procedure as an adjuvant in
the treatment of COVID-19 [18,19]. As there are no specific vaccines or
pharmaceutical products for the treatment of this disease, the use of
integrative and complementary practices, after a careful assessment of risks
and benefits, can assist in the development of protocols to control the
infection and disorders caused by SARS-CoV-2.